Pangaea Data is Attending ESMO Asia Congress 2025
Discover how Pangaea’s AI platform is closing critical care gaps by identifying more untreated and under-treated patients across hard-to-diagnose conditions, including oncological cases. The platform integrates seamlessly with EHR systems and ambient listening tools to flag insights based on insights, without disrupting existing clinical or IT workflows.
For example, in metastatic breast cancer, the platform has demonstrated the ability to determine whether patient management aligned with guideline-directed care with high accuracy—100% for biomarker testing, 97.4% for first-line therapy, and 100% for second-line therapy. These insights reveal where care deviates from clinical guidelines and provide a scalable, proactive approach to support timely interventions and improve patient outcomes.
Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai
Register to Meet Us
Attendees
